01 M.R.S. § 001-407-7 - LIMITATIONS

1. DACF is limited to paying costs of PFAS blood serum testing that are not covered by an eligible person's health insurance.

2. DACF will pay for testing no more frequently than annually.

3. DACF may pay for follow-up testing only when the applicant provides documentation from a medical provider indicating that initial test results indicate the need for enhanced medical monitoring (i.e., currently, blood serum levels above 20 nanograms per milliliter (ng/mL) according to the National Academies of Sciences, Engineering, and Medicine) and that follow-up testing is recommended. To the extent that such documentation involves the use, disclosure, access to, acquisition, or maintenance of information that actually or reasonably could identify an individual, DACF will abide by all applicable confidentiality laws, rules, and policies.

4. DACF will not pay for at-home finger-prick PFAS testing.

5. Blood may be drawn for testing in a healthcare provider's office or by a laboratory approved by the Maine Department of Health and Human Services.

6. Blood samples drawn by a health care provider or laboratory to test for blood levels of PFAS must be analyzed by a facility approved by the Maine Department of Health and Human Services.

7. Applications for PFAS blood serum testing will be reviewed by DACF PFAS Fund staff, including the PFAS Fund director. PFAS Fund staff may consult with the Maine CDC and Maine DEP to verify PFAS exposure. Decision-making authority rests with the PFAS Fund director.

8. DACF reserves the right to assess each application on a case-by-case basis and to prioritize persons who have not previously had their blood serum tested for PFAS and those exposed to PFAS for durations exceeding twelve cumulative months.

9. DACF reserves the right to limit the amount of funding for all requests based on available resources.

Notes

01 M.R.S. § 001-407-7